Barbara Pfeffer Billauer, ACSH We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a growing swarm of lawsuits threatens to…
“Revolutionary” anti-obesity drugs like Ozempic appear to be the right tool to deal with the addictive, highly processed foods that are ruining Americans’ health, former FDA Commissioner David Kessler writes at the New York Times . He says GLP-1 drugs helped him end the “cycle of despair” of weight loss and…
What You Should Know: – A new study from Mayo Clinic, released this past weekend, signals a significant advancement in understanding and potentially mitigating the challenging side effects associated with popular GLP-1 agonist medications like Wegovy and Zepbound. – Led by Mayo Clinic physician and obesity expert Andres Acosta, MD, PhD, the research reveals that … Read more
Gutgesell RM, Khalil A, Liskiewicz A, Maity-Kumar G, Novikoff A, Grandl G, Liskiewicz D, Coupland C, Karaoglu E, Akindehin S, Castelino R, Curion F, Liu X, Garcia-Caceres C, Cebrian-Serrano A, Douros JD, Knerr PJ, Finan B, DiMarchi RD, Sloop KW, Samms RJ, Theis FJ, Tschöp MH, Müller TD. GIPR agonism and antagonism decrease body weight … Read more
For all the dramatic effects of the GLP-1 agonists (and now the GLP-1/GIPR ligands as a combination), there are still a lot of mysteries around how they work. Two new papers (published simultaneously) are helping to reveal some of what’s going on, and I very much suspect that we will have more surprises to uncover. … Read more
Professor of Medicine Joel Habener. Veasey Conway/Harvard Staff Photographer Health How just a fishing expedition helped lead to GLP-1 Story of game-changing therapy illustrates crucial role of fundamental research breakthroughs Jacob Sweet Harvard Staff Writer May 8, 2025 4 min read Part of the Profiles of Progress series Sometimes an important discovery springs from a … Read more
BOSTON–(BUSINESS WIRE)–OM1: What: OM1, the leader in real-world data and AI-driven insights in mental health for life sciences, announced an upcoming poster presentation hosted by Jessica Probst, OM1’s Principal, Real World Evidence. The poster focuses on the linkage between Glucagon-like Peptide 1 Receptor Agonists (GLP-1s) and Suicidal Ideation (SI). Consistent with other findings and despite … Read more
BALTIMORE–(BUSINESS WIRE)—- $TNFA–TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health, a company committed to focusing on outpatient care to minimize costs, impact and the need for hospitalization, today announced positive results from the first stage of … Read more
Weight loss surgeries among adolescents jumped 15% between 2021 and 2023, a UT Southwestern Medical Center study found. In 2018, 9.1% of adolescents had Class II or III obesity, which is associated with a range of health issues. “Severe obesity is very common, much more common than it should be, and it is unlikely to … Read more
